LOINCActiveBoth

LOINC Code 75411-9: Ebola Zaire virus RNA NAA+probe Ql (P/Bld)

75411-9 is a LOINC code used to identify Ebola Zaire virus RNA NAA+probe Ql (P/Bld) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Ebola Zaire virus RNA. It is commonly used with the system or sample type Plas/Bld.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Ebola Zaire virus RNA. It is commonly used with the system or sample type Plas/Bld.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Both
  • Method: Probe.amp.tar

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

Ebola Zaire virus RNA [Presence] in Plasma or Blood by NAA with probe detection
Ebola Zaire virus RNA
The Ebola Zaire PCR assay presumptively detects Ebola Zaire virus, a single-stranded RNA virus identified in the 2014 West Africa outbreak. The assay is used for testing individuals with signs and symptoms of Ebola virus infection, those who are at risk for or may have been exposed to the Ebola Zaire virus, or in accordance with current public health recommendations. The definitive identification of the Ebola Zaire virus requires additional testing and confirmation procedures in consultation with public health. This term was developed for, but is not limited to, use with the Ebola Zaire Target 1 (EZ1) real-time reverse transcription (rRT) polymerase chain reaction (TaqMan®) assay (EZ1 assay), which is run on plasma or whole blood specimens. As of August 2014, the EZ1 assay is approved for use under an FDA Emergency Use Authorization (EUA) [http//www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM408334.pdf] by specified laboratories and clinical laboratory personnel who have been trained on instruments authorized by the U.S. Department of Defense.
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; EZ1; EZ1 RNA; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; PlasBld; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Ebola Zaire virus RNA NAA+probe Ql (P/Bld)Ebola Zaire virus RNA [Presence] in Plasma or Blood by NAA with probe detectionEZ1 RNA PlasBld Ql NAA+probeEbola Zaire virus RNAMICROEbola Zaire virus, BloodPrThr

Frequently asked questions

Code details

Code75411-9
SystemLOINC
Display nameEbola Zaire virus RNA NAA+probe Ql (P/Bld)
DescriptionEbola Zaire virus RNA
Short nameEZ1 RNA PlasBld Ql NAA+probe
ComponentEbola Zaire virus RNA
PropertyPrThr
TimingPt
System (specimen)Plas/Bld
ScaleOrd
MethodProbe.amp.tar
ClassMICRO
StatusACTIVE
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.50
Last changed2.63

Consumer names

Ebola Zaire virus, Blood

Part names

Ebola Zaire virus RNAPrThrPtPlas/BldOrdProbe.amp.tarPresence or ThresholdPoint in time (spot)Plasma or BloodNucleic acid amplification with probe detection

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.